ASPC

Business Context and Reporting Period

A SPAC III Acquisition Corp. (ASPC) is a blank check company incorporated in the British Virgin Islands, formed to effect a business combination with one or more businesses, specifically targeting the Environmental, Sustainability, and Governance (ESG) and material technology sectors. This Form 10-Q covers the quarter ended March 31, 2026. The Company is classified as a shell company, a smaller reporting company, and an emerging growth company. As of the reporting date, the Company has not commenced operations and has no operating revenues.

Key Financial Metrics

Note: The Trust Account balance reflects a significant reduction from the initial $60,000,000 due to shareholder redemptions in October 2025.

Material Changes vs. Prior Period

• Net Income to Net Loss: The Company reported a net loss of $113,988 for Q1 2026, compared to net income of $413,202 in Q1 2025. This shift is primarily driven by a drastic decrease in interest income earned on the Trust Account ($33,192 vs. $647,080), resulting from the reduced principal balance following mass redemptions.
• Operating Expenses: Total operating expenses decreased to $147,180 in Q1 2026 from $233,878 in Q1 2025, reflecting lower legal and professional fees ($93,400 vs. $165,494).
• Share Structure: A significant "Share Exchange" occurred on January 16, 2026, where the Sponsor exchanged 1,499,900 Class B shares for an equivalent number of Class A shares. Following this, the Sponsor holds approximately 76.4% of outstanding Class A shares.
• Trust Account Balance: The Trust Account balance increased slightly to $3,006,138 from $2,979,936 due to accrued interest, but remains significantly lower than the initial IPO proceeds due to the redemption of 5,717,419 shares in October 2025.

Outlook, Risks, and Contingencies

• Business Combination Status: The Company entered into a Merger Agreement on May 23, 2025, with Bioserica International Limited. The aggregate consideration is valued at $217,860,000, payable in newly issued PubCo shares. The transaction is subject to customary closing conditions.
• Extension and Deadline: Shareholders approved an extension of the Combination Period to November 12, 2026. If a business combination is not completed by this date, the Company will liquidate and dissolve.
• Going Concern: Management has determined that the uncertainty regarding the ability to complete a business combination and potential liquidity constraints raise substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the financial statements for potential liquidation.
• Liquidity: The Company currently holds $670,328 in cash outside the Trust Account. It may require additional financing to complete the business combination or cover working capital deficiencies, potentially through Working Capital Loans from the Sponsor.
• Risks: Risks include the failure to consummate the Bioserica merger, inability to raise additional financing, and general market volatility affecting the ability to complete a transaction.

Investor Verification Checklist

• Merger Agreement Status: Verify the current status of the Bioserica merger and whether all closing conditions have been met or are likely to be met by the November 12, 2026 deadline.
• Redemption Impact: Confirm the final number of shares remaining in the Trust Account and the per-share redemption value, given the significant redemptions in late 2025.
• Sponsor Ownership: Review the implications of the recent Share Exchange where the Sponsor converted Class B shares to Class A, resulting in a 76.4% ownership stake.
• Liquidity Sufficiency: Assess whether the current cash balance of ~$670k is sufficient to fund operations and transaction costs until the merger closes or liquidation occurs.
• Going Concern Disclosure: Monitor for any updates on the "substantial doubt" regarding the Company's ability to continue as a going concern.